Product Information
Registration Status: ActiveVITRAKVI ORAL SOLUTION 20MG/ML is approved to be sold in Singapore with effective from 2020-08-17. It is marketed by BAYER (SOUTH EAST ASIA) PTE LTD, with the registration number of SIN15993P.
This product contains Larotrectinib 20mg in the form of SOLUTION. It is approved for ORAL use.
This product is manufactured by Penn Pharmaceutical Services Limited (Bulk Production and Primary Packager) in UNITED KINGDOM.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.